{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:59:00Z","timestamp":1775141940743,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s12031-018-1063-9","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T12:35:01Z","timestamp":1530707701000},"page":"391-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Levo-tetrahydropalmatine Attenuates Neuron Apoptosis Induced by Cerebral Ischemia\u2013Reperfusion Injury: Involvement of c-Abl Activation"],"prefix":"10.1007","volume":"65","author":[{"given":"Ruoxi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichen","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-372X","authenticated-orcid":false,"given":"Shiping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","first-page":"e0148428","DOI":"10.1371\/journal.pone.0148428","volume":"11","author":"L Andresen","year":"2016","unstructured":"Andresen L, Theodorou K, Gr\u00fcnewald S, Czech-Zechmeister B, K\u00f6nnecke B, L\u00fchder F, Trendelenburg G (2016) Evaluation of the therapeutic potential of anti-TLR4-antibody MTS510 in experimental stroke and significance of different routes of application. PLoS One 11:e0148428. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0148428","journal-title":"PLoS One"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, Mao X, Shin JH, Lee Y, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Ko HS (2016) Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein-induced neurodegeneration. J Clin Investig 126:2970\u20132988. \n                    https:\/\/doi.org\/10.1172\/JCI85456","journal-title":"J Clin Investig"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1161\/STROKEAHA.108.531632","volume":"40","author":"BRS Broughton","year":"2009","unstructured":"Broughton BRS, Reutens DC, Sobey CG (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40:e331\u2013e339","journal-title":"Stroke"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00280-013-2310-y","volume":"72","author":"KS Chung","year":"2013","unstructured":"Chung KS, Han G, Kim BK, Kim HM, Yang JS, Ahn J, Lee K, Song KB, Won M (2013) A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS-mediated c-Abl\/p38 MAPK signaling. Cancer Chemother Pharmacol 72:1315\u20131324. \n                    https:\/\/doi.org\/10.1007\/s00280-013-2310-y","journal-title":"Cancer Chemother Pharmacol"},{"key":"1063_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-pharmtox-010716-105001","volume":"57","author":"TM Dawson","year":"2017","unstructured":"Dawson TM, Dawson VL (2017) Mitochondrial mechanisms of neuronal cell death: potential therapeutics. Annu Rev Pharmacol Toxicol 57:437\u2013454. \n                    https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-105001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"e38627","DOI":"10.1371\/journal.pone.0038627","volume":"7","author":"Y Han","year":"2012","unstructured":"Han Y, Zhang W, Tang Y, Bai W, Yang F, Xie L, Li X, Zhou S, Pan S, Chen Q, Ferro A, Ji Y (2012) L-tetrahydropalmatine, an active component of corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats. PLoS One 7:e38627. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0038627","journal-title":"PLoS One"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1280","volume":"5","author":"O Hantschel","year":"2004","unstructured":"Hantschel O, Superti-Furga G (2004) Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol 5:33\u201344","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1063_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","volume":"388","author":"JS Healey","year":"2016","unstructured":"Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, Commerford P, Jansky P, Avezum A, Sigamani A (2016) Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet 388:1161\u20131169","journal-title":"Lancet"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1128\/MCB.21.18.6233-6242.2001","volume":"21","author":"Y Ito","year":"2001","unstructured":"Ito Y, Pandey P, Mishra NC, Kumar S, Narula N, Kharbanda S, Saxena S, Kufe D (2001) Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol Cell Biol 21:6233\u20136242. \n                    https:\/\/doi.org\/10.1128\/MCB.21.18.6233","journal-title":"Mol Cell Biol"},{"key":"1063_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12035-010-8102-z","volume":"41","author":"JE Jung","year":"2010","unstructured":"Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, Niizuma K, Katsu M, Okami N, Yoshioka H, Sakata H, Goeders CE, Chan PH (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41:172\u2013179","journal-title":"Mol Neurobiol"},{"key":"1063_CR11","doi-asserted-by":"publisher","unstructured":"Kang D-W, Moon J-Y, Choi J-G, Kang SY, Ryu Y, Park JB, Lee JH, Kim HW (2016) Antinociceptive profile of levo-tetrahydropalmatine in acute and chronic pain mice models: role of spinal sigma-1 receptor. Sci Rep 6. doi:\n                    https:\/\/doi.org\/10.1038\/srep37850","DOI":"10.1038\/srep37850"},{"key":"1063_CR12","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/j.1471-4159.2009.06112.x","volume":"109","author":"S Karunakaran","year":"2009","unstructured":"Karunakaran S, Ravindranath V (2009) Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-??B in MPTP-treated mice: implication in Parkinson\u2019s disease. J Neurochem 109:1791\u20131799. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06112.x","journal-title":"J Neurochem"},{"key":"1063_CR13","doi-asserted-by":"publisher","unstructured":"Karuppagounder SS, Brahmachari S, Lee Y, Dawson VL, Dawson TM, Ko HS (2014) The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson\u2019s disease. Sci Rep 4. doi:\n                    https:\/\/doi.org\/10.1038\/srep04874","DOI":"10.1038\/srep04874"},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1128\/MCB.20.14.4979-4989.2000","volume":"20","author":"S Kharbanda","year":"2000","unstructured":"Kharbanda S, Pandey P, Yamauchi T, Kumar S, Kaneki M, Kumar V, Bharti A, Yuan ZM, Ghanem L, Rana A, Weichselbaum R, Johnson G, Kufe D (2000) Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol Cell Biol 20:4979\u20134989. \n                    https:\/\/doi.org\/10.1128\/MCB.20.14.4979-4989.2000","journal-title":"Mol Cell Biol"},{"key":"1063_CR15","doi-asserted-by":"publisher","unstructured":"Mao XW, Pan CS, Huang P, Liu YY, Wang CS, Yan L, Hu BH, Chang X, He K, Mu HN, Li Q, Sun K, Fan JY, Han JY (2015) Levo-tetrahydropalmatine attenuates mouse blood-brain barrier injury induced by focal cerebral ischemia and reperfusion: involvement of Src kinase. Sci Rep 5. doi:\n                    https:\/\/doi.org\/10.1038\/srep11155","DOI":"10.1038\/srep11155"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/eji.200940168","volume":"40","author":"F Martinon","year":"2010","unstructured":"Martinon F (2010) Signaling by ROS drives inflammasome activation. Eur J Immunol 40:616\u2013619","journal-title":"Eur J Immunol"},{"key":"1063_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67:181\u2013198","journal-title":"Neuron"},{"key":"1063_CR18","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1074\/jbc.R112.438382","volume":"288","author":"S Panjarian","year":"2013","unstructured":"Panjarian S, Iacob RE, Chen S, Engen JR, Smithgall TE (2013) Structure and dynamic regulation of abl kinases. J Biol Chem 288:5443\u20135450","journal-title":"J Biol Chem"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12031-011-9588-1","volume":"45","author":"SD Schlatterer","year":"2011","unstructured":"Schlatterer SD, Acker CM, Davies P (2011) C-Abl in neurodegenerative disease. J Mol Neurosci 45:445\u2013452","journal-title":"J Mol Neurosci"},{"key":"1063_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12883-016-0765-2","volume":"16","author":"O Shafi","year":"2016","unstructured":"Shafi O (2016) Inverse relationship between Alzheimer\u2019s disease and cancer, and other factors contributing to Alzheimer\u2019s disease: a systematic review. BMC Neurol 16:236. \n                    https:\/\/doi.org\/10.1186\/s12883-016-0765-2","journal-title":"BMC Neurol"},{"key":"1063_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","volume":"133","author":"CJ Sommer","year":"2017","unstructured":"Sommer CJ (2017) Ischemic stroke: experimental models and reality. Acta Neuropathol 133:245\u2013261","journal-title":"Acta Neuropathol"},{"key":"1063_CR22","doi-asserted-by":"publisher","first-page":"17237","DOI":"10.1074\/jbc.C000099200","volume":"275","author":"X Sun","year":"2000","unstructured":"Sun X, Majumder P, Shioya H, Wu F, Kumar S, Weichselbaum R, Kharbanda S, Kufe D (2000) Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J Biol Chem 275:17237\u201317240. \n                    https:\/\/doi.org\/10.1074\/jbc.C000099200","journal-title":"J Biol Chem"},{"key":"1063_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4155\/fmc.11.166","volume":"4","author":"JB Wang","year":"2012","unstructured":"Wang JB, Mantsch JR (2012) l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction. Future Med Chem 4:177\u2013186. \n                    https:\/\/doi.org\/10.4155\/fmc.11.166","journal-title":"Future Med Chem"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2015.06.016","volume":"600","author":"X Wang","year":"2015","unstructured":"Wang X, Li R, Wang X, Fu Q, Ma S (2015) Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP\/NLRP3 inflammasome. Neurosci Lett 600:182\u2013187. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2015.06.016","journal-title":"Neurosci Lett"},{"key":"1063_CR25","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1007\/s12035-015-9607-2","volume":"53","author":"W Wang","year":"2016","unstructured":"Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q, Wang J (2016) GSK-3\u03b2 inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt\/\u03b2-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol 53:7028\u20137036. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9607-2","journal-title":"Mol Neurobiol"},{"key":"1063_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/cdd.2015.135","volume":"23","author":"R Wu","year":"2016","unstructured":"Wu R, Chen H, Ma J, He Q, Huang Q, Liu Q, Li M, Yuan Z (2016) C-Abl-p38\u03b1 signaling plays an important role in MPTP-induced neuronal death. Cell Death Differ 23:542\u2013552. \n                    https:\/\/doi.org\/10.1038\/cdd.2015.135","journal-title":"Cell Death Differ"},{"key":"1063_CR27","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1002\/jcb.26010","volume":"118","author":"YD Xu","year":"2017","unstructured":"Xu YD, Cui C, Sun MF et al (2017) Neuroprotective effects of loganin on MPTP-induced Parkinson\u2019s disease mice: neurochemistry, glial reaction and autophagy studies. J Cell Biochem 118:3495\u20133510. \n                    https:\/\/doi.org\/10.1002\/jcb.26010","journal-title":"J Cell Biochem"},{"key":"1063_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/187152411794961040","volume":"11","author":"S Yasuda","year":"2011","unstructured":"Yasuda S, Sugiura H, Tanaka H, Takigami S, Yamagata K (2011) p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases. Cent Nerv Syst Agents Med Chem 11:45\u201359. \n                    https:\/\/doi.org\/10.2174\/187152411794961040","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"1063_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2012.03.014","volume":"102","author":"K Yue","year":"2012","unstructured":"Yue K, Ma B, Ru Q, Chen L, Gan Y, Wang D, Jin G, Li C (2012) The dopamine receptor antagonist levo-tetrahydropalmatine attenuates heroin self-administration and heroin-induced reinstatement in rats. Pharmacol Biochem Behav 102:1\u20135. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2012.03.014","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-018-1063-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:25:34Z","timestamp":1562181934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-018-1063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s12031-018-1063-9","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"28 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the Animal Ethics Committee of China Pharmaceutical University and was in agreement with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}